Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Código QR

Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/3507472f96914934b6c4a2a7122da768
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Acta N°1275
por: Banco Central de Chile
Publicado: (2021)

Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
por: Hua Zhao, et al.
Publicado: (2021)

Epigenomics and immunotherapeutic advances in pediatric brain tumors
por: Malak Abedalthagafi, et al.
Publicado: (2021)

Modulation of Epstein-Barr Virus Glycoprotein B (gB) Fusion Activity by the gB Cytoplasmic Tail Domain
por: Nicholas J. Garcia, et al.
Publicado: (2013)

Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement
por: Ai Lin Chin, et al.
Publicado: (2021)

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
por: Yoshimasa Tanaka, et al.
Publicado: (2017)

Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
por: Chanyoung Song, et al.
Publicado: (2019)

Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
por: Ariane Desselle, et al.
Publicado: (2012)

Immunotherapeutic Advances for NSCLC
por: Massafra M, et al.
Publicado: (2021)

Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
por: Hei Y, et al.
Publicado: (2020)

Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
por: Ronald D. Seidel, et al.
Publicado: (2021)

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Thomas Duhen, et al.
Publicado: (2018)

TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
por: F. Linzee Mabrey, et al.
Publicado: (2021)

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Pengju Wang, et al.
Publicado: (2018)

Novel Immunotherapeutic Approach in Gastric Cancer
por: Gulubova M., et al.
Publicado: (2020)

Immunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme B.
por: Mathias Gehrmann, et al.
Publicado: (2012)

Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures
por: Mengqi Huo, et al.
Publicado: (2020)

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Pengju Wang, et al.
Publicado: (2017)

Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
por: O'Donnell KL, et al.
Publicado: (2021)

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Sandra Thiel, et al.
Publicado: (2021)

Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
por: Dale Christiansen, et al.
Publicado: (2008)

Experimental Demonstration of 40-Gb/s I-SC-FDM With 10G-Class Optics and Low-Complexity DSP for Next-Generation PON
por: Xizi Tang, et al.
Publicado: (2018)

Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Jana Mihályová, et al.
Publicado: (2021)

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
por: Aitziber Buqué, et al.
Publicado: (2020)

Integrin CD11b activation drives anti-tumor innate immunity
por: Michael C. Schmid, et al.
Publicado: (2018)

The functions of еру modal verb «should» in the corpus ice-gb
por: R. Y. Abbasov
Publicado: (2014)

Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
por: Ping Zeng, et al.
Publicado: (2017)

Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
por: Ping Zeng, et al.
Publicado: (2021)

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
por: Aitziber Buqué, et al.
Publicado: (2020)

Ponomareva G.B. Dostoevsky: I Am Working on This Mystery. Review
por: Olga A. Bogdanova
Publicado: (2020)

CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells
por: Myung-Chul Kim, et al.
Publicado: (2021)

Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.
por: C Wim Ang, et al.
Publicado: (2010)

Optimizing the Schedule of PARP Inhibitors in Combination with <sup>177</sup>Lu-DOTATATE: A Dosimetry Rationale
por: Andreas Hallqvist, et al.
Publicado: (2021)

SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
por: T. S. Nepomnyashchikh, et al.
Publicado: (2017)

MOTIVATING DELEGATION MODEL AND ITS RATIONALE
por: A. A. Dolgaya
Publicado: (2020)

The NSABB Recommendations: Rationale, Impact, and Implications
por: Paul S. Keim
Publicado: (2012)

The rationale of European countries engage in AIIB
por: Bora Ly
Publicado: (2020)

Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect
por: Chen E, et al.
Publicado: (2020)

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials
por: Giuseppe Cabibbo, et al.
Publicado: (2021)

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
por: Ahmed Al‑Darraji, et al.
Publicado: (2021)